OutSee Selected for Discovery Award from Longitude Prize on ALS to Accelerate AI-based Target Discovery
- Funding to identify novel targets for ALS treatment using OutSee’s ‘genomics first’ target discovery platform, Nomaly
- Provides access to world’s largest and most comprehensive ALS patient dataset
- Part of £7.5M global challenge prize to leverage innovations in AI-based discovery